Delivery Order SPE2DB20D6037-SPE2DB24FTTZ3

Award Date 11/27/23
Potential Completion Date 11/28/23
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain program, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,434.00, is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4557384457 NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $3,420.00. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,557,954,905 units of Naloxone hydrochloride 4 mg nasal spray. The contract has a ceiling value of $5,266.28 and an ultimate completion date of August 2, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
This is a Delivery Order (DO) contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is valued at $1,434.00 and has a period of performance through September 3, 2021. The contract provides for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. This DO is part of a larger Indefinite Delivery Contract (IDC) with DMS...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,727.05 firm fixed-price contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of 4565107884 - NALOXONE HYDROCHLOR10. There is no set-aside designation associated with this award. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by...
This firm-fixed-price delivery order, valued at $2,473.12, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of Naloxone Hydrochloride Injection 0.4 mg/mL, 1 mL, to support the recurring medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) under their Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $1,352.33 firm fixed-price delivery order is for the supply of 4565531075 - NALOXONE 2 MG/2 ML SYRINGE 2ML, with a completion date of August 16, 2024. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of naloxone hydrochloride, with a completion date of March 4, 2024 and a potential value of $1,036.80. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,434.00 and has a firm fixed price pricing type. The contract is for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to...
The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563194670 - NALOXONE 2 MG/2 ML SYRINGE 2ML. The award has a potential value of $1,594.20 and a completion date of December 26, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to support...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTTZ3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 4562900589 - NALOXONE 2 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $1,529.30 and a period of performance through November 28, 2023.

The contract is a firm fixed-price delivery order, with no set-aside designation, issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 10/23/24, 9:32 AM